Literature DB >> 19244054

Patients with plasma cell disorders examined at whole-body dynamic contrast-enhanced MR imaging: initial experience.

Chieh Lin1, Alain Luciani, Karim Belhadj, Patrick Maison, Alexandre Vignaud, Jean-François Deux, Pierre Zerbib, Frédéric Pigneur, Emmanuel Itti, Hicham Kobeiter, Corinne Haioun, Alain Rahmouni.   

Abstract

UNLABELLED: This study was approved by the institutional review board, and informed consent was obtained from all subjects. The authors prospectively evaluated the feasibility of multistation whole-body dynamic contrast material-enhanced magnetic resonance (MR) imaging performed in patients with plasma cell disorders to assess disease extension and the time-signal intensity curves of diffuse and focal bone marrow infiltration. Three healthy adult male volunteers (age range, 29-31 years) and 21 patients (12 men, nine women; age range, 34-79 years) underwent whole-body dynamic unenhanced (volunteers) and contrast-enhanced MR imaging, which was performed by using an 18-channel 1.5-T MR system. A five-station (three sagittal and two coronal planes) fat-saturated three-dimensional gradient-echo sequence (3.3-3.6/1.3 [repetition time msec/echo time msec], 20 degrees flip angle, voxel size of 2 x 2.6 x [3-5] mm) was performed seven times. The temporal resolution of the five-station dynamic contrast-enhanced examination was 60 seconds with use of parallel imaging. Time-signal intensity curves for the bone marrow and the focal lesions were successfully obtained in all patients. SUPPLEMENTAL MATERIAL: http://radiology.rsnajnls.org/cgi/content/full/250/3/905/DC1http://radiology.rsnajnls.org/cgi/content/full/250/3/905/DC2http://radiology.rsnajnls.org/cgi/content/full/250/3/905/DC3. RSNA, 2009

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19244054     DOI: 10.1148/radiol.2503081017

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  (11)C-acetate as a new biomarker for PET/CT in patients with multiple myeloma: initial staging and postinduction response assessment.

Authors:  Chieh Lin; Chi-Lai Ho; Shu-Hang Ng; Po-Nan Wang; Yenlin Huang; Yu-Chun Lin; Tzung-Chih Tang; Shu-Fan Tsai; Alain Rahmouni; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-16       Impact factor: 9.236

2.  Imaging of the entire cerebrospinal fluid volume with a multistation 3D SPACE MR sequence: feasibility study in patients with hydrocephalus.

Authors:  Jérôme Hodel; Alain Lebret; Eric Petit; Xavier Leclerc; Marc Zins; Alexandre Vignaud; Philippe Decq; Alain Rahmouni
Journal:  Eur Radiol       Date:  2012-12-13       Impact factor: 5.315

3.  Early response assessment in patients with multiple myeloma during anti-angiogenic therapy using arterial spin labelling: first clinical results.

Authors:  Michael Fenchel; Marina Konaktchieva; Katja Weisel; Sabina Kraus; Harald Brodoefel; Claus D Claussen; Marius Horger
Journal:  Eur Radiol       Date:  2010-07-01       Impact factor: 5.315

Review 4.  Multiple myeloma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2010-02-11       Impact factor: 3.909

5.  Role of whole-body 64-slice multidetector computed tomography in treatment planning for multiple myeloma.

Authors:  Ahmed Abdel Khalek Abdel Razek; Amany Ezzat; Emad Azmy; Nehal Tharwat
Journal:  Radiol Med       Date:  2012-09-17       Impact factor: 3.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.